Allergan receives written requests for special stockholder meeting

Allergan has received stockholders’ written requests for a special stockholders’ meeting. The requests were delivered by Pershing Square Capital Management, which is attempting to complete a merger between Allergan and Valeant Pharmaceuticals. As part of the special meeting, Allergan stockholders would be asked to replace a majority of the company’s existing directors and address other matters related to Valeant’s merger proposal, according to a press release from Allergan.

Full Story →